1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Strontium-89: new trials by email Literature Review of Strontium-89 trials Research Report on Strontium-89
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer Calcium, Vitamin D, zoledronic acid - Breast Cancer, Lung Cancer | Phase 3 | Completed | Radiation Therapy Oncology Group | 261 | 2006-07-11 | 2024-09-20 |
| Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer Docetaxel, Doxorubicin hydrochloride, Estramustine phosphate sodium - Prostate Cancer | Phase 3 | Terminated | M.D. Anderson Cancer Center | 265 | 2002-04-01 | 2016-03-22 |
Prostatic Neoplasms (2) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Pain (1)
M.D. Anderson Cancer Center (1) · Radiation Therapy Oncology Group (1)
United States (2)
Michael J. Seider, MD, PhD, FACR (1) · Shi-Ming Tu, MD (1)
P30CA016672 (1), U10CA045809 (1)